| US 7,566,733 B2 | ||
| Benzimidazole derivatives useful as selective androgen receptor modulators (sarms) | ||
| Raymond Ng, Raritan, N.J. (US); Zhihua Sui, Raritan, N.J. (US); Jihua Guan, Raritan, N.J. (US); James C. Lanter, Raritan, N.J. (US); and Vernon C. Alford, Jr., Raritan, N.J. (US) | ||
| Assigned to Janssen Pharmaceutica N.V., Beerse (Belgium) | ||
| Filed on Sep. 26, 2005, as Appl. No. 11/235,024. | ||
| Claims priority of provisional application 60/614751, filed on Sep. 30, 2004. | ||
| Prior Publication US 2006/0116412 A1, Jun. 01, 2006 | ||
| Int. Cl. A61K 31/4184 (2006.01); C07D 235/10 (2006.01); C07D 235/12 (2006.01) | ||
| U.S. Cl. 514—394 [548/309.7; 548/310.1] | 3 Claims |
| 1. A compound selected from
1-(5,6-dichloro-1H-benzimidazol-2-yl)-2,2,2-trifluoro-ethanol;
3-(5,6-dichloro-1H-benzimidazol-2-yl)-3-hydroxy-butyronitrile;
or a pharmaceutically acceptable salt thereof.
|